BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26670126)

  • 1. Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.
    Korpershoek E; Koffy D; Eussen BH; Oudijk L; Papathomas TG; van Nederveen FH; Belt EJ; Franssen GJ; Restuccia DF; Krol NM; van der Luijt RB; Feelders RA; Oldenburg RA; van Ijcken WF; de Klein A; de Herder WW; de Krijger RR; Dinjens WN
    J Clin Endocrinol Metab; 2016 Feb; 101(2):453-60. PubMed ID: 26670126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
    Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
    Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.
    Comino-Méndez I; Gracia-Aznárez FJ; Schiavi F; Landa I; Leandro-García LJ; Letón R; Honrado E; Ramos-Medina R; Caronia D; Pita G; Gómez-Graña A; de Cubas AA; Inglada-Pérez L; Maliszewska A; Taschin E; Bobisse S; Pica G; Loli P; Hernández-Lavado R; Díaz JA; Gómez-Morales M; González-Neira A; Roncador G; Rodríguez-Antona C; Benítez J; Mannelli M; Opocher G; Robledo M; Cascón A
    Nat Genet; 2011 Jun; 43(7):663-7. PubMed ID: 21685915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation.
    Romanet P; Guerin C; Pedini P; Essamet W; Castinetti F; Sebag F; Roche P; Cascon A; Tischler AS; Pacak K; Barlier A; Taïeb D
    Endocr Pathol; 2017 Dec; 28(4):302-307. PubMed ID: 27838885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
    Seabrook AJ; Harris JE; Velosa SB; Kim E; McInerney-Leo AM; Dwight T; Hockings JI; Hockings NG; Kirk J; Leo PJ; Love AJ; Luxford C; Marshall M; Mete O; Pennisi DJ; Brown MA; Gill AJ; Hockings GI; Clifton-Bligh RJ; Duncan EL
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1163-1182. PubMed ID: 33367756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Acromegaly and Bilateral Asynchronous Pheochromocytomas in a Female Patient With a
    Mamedova E; Vasilyev E; Petrov V; Buryakina S; Tiulpakov A; Belaya Z
    Front Endocrinol (Lausanne); 2021; 12():683492. PubMed ID: 34135865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant.
    Duarte DB; Ferreira L; Santos AP; Costa C; Lima J; Santos C; Afonso M; Teixeira MR; Carvalho R; Cardoso MH
    Front Endocrinol (Lausanne); 2021; 12():609263. PubMed ID: 33815275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Phenotype of Germline Pathogenic Variants in
    Chang X; Li Z; Ma X; Cui Y; Chen S; Tong A
    Front Endocrinol (Lausanne); 2020; 11():558. PubMed ID: 32973681
    [No Abstract]   [Full Text] [Related]  

  • 9. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours.
    Crona J; Maharjan R; Delgado Verdugo A; Stålberg P; Granberg D; Hellman P; Björklund P
    Fam Cancer; 2014 Mar; 13(1):121-5. PubMed ID: 23743562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
    Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
    Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
    Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
    McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and in silico assessment of MAX variants of unknown significance.
    Comino-Méndez I; Leandro-García LJ; Montoya G; Inglada-Pérez L; de Cubas AA; Currás-Freixes M; Tysoe C; Izatt L; Letón R; Gómez-Graña Á; Mancikova V; Apellániz-Ruiz M; Mannelli M; Schiavi F; Favier J; Gimenez-Roqueplo AP; Timmers HJ; Roncador G; Garcia JF; Rodríguez-Antona C; Robledo M; Cascón A
    J Mol Med (Berl); 2015 Nov; 93(11):1247-55. PubMed ID: 26070438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion.
    Petignot S; Daly AF; Castermans E; Korpershoek E; Scagnol I; Beckers P; Dideberg V; Rohmer V; Bours V; Beckers A
    Horm Metab Res; 2020 Nov; 52(11):784-787. PubMed ID: 32521546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
    Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
    Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
    Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
    Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of juvenile-onset pheochromocytoma with KIF1B p.V1529M germline mutation.
    Nezu M; Hirotsu Y; Amemiya K; Katsumata M; Watanabe T; Takizawa S; Inoue M; Mochizuki H; Hosaka K; Oyama T; Omata M
    Endocr J; 2022 Jun; 69(6):705-716. PubMed ID: 35046208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.